Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

NCT06099730 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06099730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06099730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 14, 2023
Completion date
December 31, 2028
Enrollment
442 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation